Related Experiment Video
Updated: Jun 7, 2025

MRI-guided dmPFC-rTMS as a Treatment for Treatment-resistant Major Depressive Disorder
Published on: August 11, 2015
Transformative Therapies for Depression: Postpartum Depression, Major Depressive Disorder, and Treatment-Resistant
Elizabeth Richardson1, Riah Patterson1, Samantha Meltzer-Brody1
1Department of Psychiatry, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA;
Abstract:
Depressive disorders present an enormous global public health burden. A notable treatment gap exists between the prevalence of depression and our ability to provide rapid-acting, effective treatment that achieves remission. Brexanolone and zuranolone, the first US Food and Drug Administration-approved drugs for postpartum depression, signify a critical advancement in addressing the unmet needs of a vulnerable patient population. Psilocybin shows promise for treatment-resistant depression and for those who have struggled to find relief with existing treatments. This review discusses transformative therapies that represent significant advancements in postpartum depression, major depressive disorder, and treatment-resistant depression.
More Related Videos
Related Concept Videos
Psychotherapy
Electroconvulsive Therapy
Cognitive Therapy
Treatment Strategies for Psychological Disorders
Psychological therapies focus on modifying emotions, thoughts, and behaviors through talking, interpreting, listening, rewarding, challenging, and modeling. Clinical psychologists, counselors, and social workers commonly practice psychotherapy. Clinical...
Psychodynamic Therapy
Antidepressant Drugs: MAOIs and Other Agents

